Aggreguide A-100 ADP Assay Evaluation

Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02112539

Enrollment

150

Registered

2014-04-14

Start date

2014-03-31

Completion date

2014-08-31

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADP Blockers, Platelet Aggregation

Brief summary

The study is to characterize the AggreGuide ADP Assay's performance.

Interventions

OTHERplatelet aggregation measurement

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-75

Exclusion criteria

* less than 60 kg * on antiplatelet meds other than aspirin * antiplatelet drugs contraindicated

Design outcomes

Primary

Measure	Time frame	Description
Platelet Activity Index (PAI)	1 week	PAI at baseline and after taking ADP blocking antiplatelet drugs.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026